TITLE

MDMX Inhibits the p300/CBP-Mediated Acetylation of p53

AUTHOR(S)
Sabbatini, Peter; McCormick, Frank
PUB. DATE
July 2002
SOURCE
DNA & Cell Biology;Jul2002, Vol. 21 Issue 7, p519
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The p300/CBP-mediated acetylation of p53 significantly potentiates p53-mediated transactivation and growth inhibition. MDM2 inhibits the acetylation of p53 by p300/CBP through a mechanism that requires a stable p53-MDM2 interaction and that is sensitive to the deacetylase inhibitor, TSA. MDMX is an MDM2-like protein that shares with MDM2 the ability to interact with p53 and, in turn, inhibit p53-mediated transcription. It was therefore of interest to determine if MDMX could also inhibit the acetylation of p53 by p300/CBP. We demonstrate that MDMX dramatically inhibits the acetylation of p53 induced by both endogenous and ectopically expressed p300/CBP. We also demonstrate that the p53-binding domain of MDMX is required for the MDMX-mediated inhibition of p53 acetylation. Our results indicate that MDMX shares with MDM2 the ability to regulate a potentially important post-translational modification of p53. These results may have important biologic implications with respect to the MDMX-mediated regulation of p53 activity during development.
ACCESSION #
7057330

 

Related Articles

  • iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Bergamaschi, Daniele; Samuels, Yardena; O'Neil, Nigel J.; Trigiante, Giuseppe; Crook, Tim; Jung-Kuang Hsieh; O'Connor, Daniel J.; Shan Zhong; Campargue, Isabelle; Tomlinson, Matthew L.; Kuwabara, Patricia E.; Xin Lu // Nature Genetics;Feb2003, Vol. 33 Issue 2, p162 

    We have previously shown that ASPP1 and ASPP2 are specific activators of p53; one mechanism by which wild-type p53 is tolerated in human breast carcinomas is through loss of ASPP activity. We have further shown that 53BP2, which corresponds to a C-terminal fragment of ASPP2, acts as a dominant...

  • Down regulation of p53 with HPV E6 delays and modifies cell death in oxidant response of human diploid fibroblasts: an apoptosis-like cell death associated with mitosis. Chen, Qin M.; Merrett, Jessica B.; Dilley, Tarrah; Purdom, Sally // Oncogene;8/8/2002, Vol. 21 Issue 34, p5313 

    Presents a study which tested the hypothesis that inactivating tumor suppressor p53 protein with E6 gene delays cell death and studied the mechanism related to p53 independent cell death. Role of cell death in tissue homeostasis; Forms of cell death observed after injury or toxic stress;...

  • Chimeric oncoprotein E2a-Pbx1 induces apoptosis of hematopoietic cells by a p53-independent mechanism that is suppressed by Bcl-2. Smith, Kevin S; Jacobs, Yakop; Chang, Ching-Pin; Cleary, Michael L // Oncogene;6/19/97, Vol. 14 Issue 24, p2917 

    The chimeric oncoprotein E2a-Pbx1 results from fusion of the E2A and PBX1 genes following t(1;19) chromosomal translocations in B cell precursor acute leukemias. Experimentally B cell progenitors do not tolerate constitutive expression of E2a-Pbx1 which contrasts with transformation of several...

  • Tumor Protein 73.  // Encyclopedic Reference of Cancer;2001, p925 

    A definition of the term "tumor protein 73" is presented. It refers to a protein that activates transcription of p53 responsive genes and inhibits cell growth by apoptosis. It maps to locus 1p36, and is a member of p53 gene family.

  • Acetylation of Lysine 382 and Phosphorylation of Serine 392 in p53 Modulate the Interaction between p53 and MDC1 In Vitro. Shahar, Or David; Gabizon, Ronen; Feine, Oren; Alhadeff, Raphael; Ganoth, Assaf; Argaman, Liron; Shimshoni, Elee; Friedler, Assaf; Goldberg, Michal // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Occurrence of DNA damage in a cell activates the DNA damage response, a survival mechanism that ensures genomics stability. Two key members of the DNA damage response are the tumor suppressor p53, which is the most frequently mutated gene in cancers, and MDC1, which is a central adaptor that...

  • Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. Roth, Judith; Dobbelstein, Matthias; Freedman, Deborah A.; Shenk, Thomas; Levine, Arnold J. // EMBO Journal;1/15/98, Vol. 17 Issue 2, p554 

    The hdm2 gene is overexpressed in a variety of human tumors. Its gene product localizes predominantly to the nucleus, where it acts as an inhibitor of the p53 tumor suppressor gene product. It is shown here that the hdm2 oncoprotein constantly shuttles between the nucleus and the cytoplasm....

  • Tumour suppression: Full on. Alderton, Gemma K. // Nature Reviews Cancer;Sep2009, Vol. 9 Issue 9, p612 

    The article reports on a study by Geoffrey Wahl regarding the role played by MDM4 human gene in regulating the activity and tumour-suppressive effects of p53 tumor protein. Researchers produce an MDM4-mutant mouse in which serine residues that are phosphorylated by the DNA damage response...

  • TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression. Seux, M; Peuget, S; Montero, M P; Siret, C; Rigot, V; Clerc, P; Gigoux, V; Pellegrino, E; Pouyet, L; N'Guessan, P; Garcia, S; Dufresne, M; Iovanna, J L; Carrier, A; André, F; Dusetti, N J // Oncogene;7/1/2011, Vol. 30 Issue 27, p3049 

    Tumor protein 53 induced nuclear protein 1 (TP53INP1) is a p53 target gene that induces cell growth arrest and apoptosis by modulating p53 transcriptional activity. TP53INP1 interacts physically with p53 and is a major player in the p53-driven oxidative stress response. Previously, we...

  • HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53. Meulendijks, D; Tomasoa, N B; Dewit, L; Smits, P H M; Bakker, R; van Velthuysen, M-L F; Rosenberg, E H; Beijnen, J H; Schellens, J H M; Cats, A // British Journal of Cancer;4/14/2015, Vol. 112 Issue 8, p1358 

    Background:Human papillomavirus (HPV), p16 expression, and TP53 mutations are known prognostic factors in head and neck squamous cell carcinoma, but their role in squamous cell carcinoma of the anal canal (SCCAC) is less well established. The objective of this study was to determine the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics